Núria Reig
Directeur Technique/Scientifique/R&D chez SOM Innovation Biotech SA
Postes actifs de Núria Reig
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SOM Innovation Biotech SA
 SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Núria Reig
Anciens postes connus de Núria Reig
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EPFL Plus | Corporate Officer/Principal | - | - |
| Yale University | Corporate Officer/Principal | - | - |
| University of Geneva | Corporate Officer/Principal | - | - |
Formation de Núria Reig
| University of Barcelona | Doctorate Degree |
Statistiques
Internationale
| Espagne | 3 |
| Suisse | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| EPFL Plus | |
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Health Technology |
- Bourse
- Insiders
- Núria Reig
- Expérience
